Table 3.
Available pandemic H1N1v 2009 vaccine viruses (as of October 2009) 1.
| Parent virus | Vaccine virus | Developing institute 2 | Available since |
|---|---|---|---|
| A/California/07/2009 | Wild type | CDC | May 09 |
| X-179A cl | NYMC | 27 May 09 | |
| IVR-153 cl | CSL | 04 June 09 | |
| X-181 cl | NYMC | 14 Sept 09 | |
| X-181A cl | NYMC | 14 Sept 09 | |
| NIBRG-121 rg | NIBSC | 27 May 09 | |
| NIBRG-121xp rg | NIBSC | 06 Aug 09 | |
| A/California/04/2009 | Wild type | CDC | May 09 |
| CBER-RG2 rg | CBER | 19 June 09 | |
| A/Texas/5/2009 | Wild type | CDC | May 09 |
| IDCDC-RG15 rg | CDC | 27 May 09 | |
| IDCDC-RG20 rg | CDC | 22 July 09 | |
| A/England/195/2009 | Wild type | NIBSC | May 09 |
| NIBRG-122 rg | NIBSC | 22 July 09 | |
| A/Texas/5/2009 & A/New York/18/2009 | IDCDC-RG18 rg | CDC | 22 July 09 |
| A/New York/18/2009 | IDCDC-RG22 rg | CDC | 22 July 09 |
1
Reproduced with permission from reference [51] (World Health Organization).
2
CBER–Centers for Biologics Evaluation and Research, USA; CDC–Centers for Disease Control and Prevention, USA; CSL–Commonwealth Serum Laboratories, Australia; NYMC–New York Medical College, USA; NIBSC–National Institute for Biological Standards and Control, UK.
cl
classical reassortant
rg
reverse genetics derived